CEQUA Drug Patent Profile

✉ Email this page to a colleague

When do Cequa patents expire, and what generic alternatives are available?

Cequa is a drug marketed by Sun Pharm and is included in one NDA. There are four patents protecting this drug.

This drug has thirty-six patent family members in twenty-four countries.

The generic ingredient in CEQUA is cyclosporine. There are eighteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Cequa

A generic version of CEQUA was approved as cyclosporine by HIKMA on October 29^th, 1999.

Try a Trial

Summary for CEQUA

International Patents:	36
US Patents:	4
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	89
Patent Applications:	4,337
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for CEQUA
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for CEQUA
What excipients (inactive ingredients) are in CEQUA?	CEQUA excipients list
DailyMed Link:	CEQUA at DailyMed

Drug patent expirations by year for CEQUA

Pharmacology for CEQUA

Drug Class	Calcineurin Inhibitor Immunosuppressant
Mechanism of Action	Calcineurin Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors

US Patents and Regulatory Information for CEQUA

CEQUA is protected by four US patents.

Patents protecting CEQUA

Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

Topical cyclosporine-containing formulations and uses thereof
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

Topical aqueous nanomicellar, ophthalmic solutions and uses thereof
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: INCREASE TEAR PRODUCTION IN PATIENTS WITH KERATOCONJUNCTIVITIS SICCA (DRY EYE).

Topical formulations and uses thereof
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: INCREASE TEAR PRODUCTION IN PATIENTS WITH KERATOCONJUNCTIVITIS SICCA (DRY EYE).

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sun Pharm	CEQUA	cyclosporine	SOLUTION;OPHTHALMIC	210913-001	Aug 14, 2018		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
Sun Pharm	CEQUA	cyclosporine	SOLUTION;OPHTHALMIC	210913-001	Aug 14, 2018		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
Sun Pharm	CEQUA	cyclosporine	SOLUTION;OPHTHALMIC	210913-001	Aug 14, 2018		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
Sun Pharm	CEQUA	cyclosporine	SOLUTION;OPHTHALMIC	210913-001	Aug 14, 2018		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for CEQUA

See the table below for patents covering CEQUA around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Brazil	112018067946	formulações tópicas contendo ciclosporina e usos das mesmas	⤷ Try a Trial
European Patent Office	3423076	FORMULATIONS À USAGE TOPIQUE CONTENANT DE LA CYCLOSPORINE ET LEURS UTILISATIONS (TOPICAL CYCLOSPORINE-CONTAINING FORMULATIONS AND USES THEREOF)	⤷ Try a Trial
Spain	2948387		⤷ Try a Trial
Australia	2022203135	TOPICAL CYCLOSPORINE-CONTAINING FORMULATIONS AND USES THEREOF	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2014032026		⤷ Try a Trial
Poland	2887923		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for CEQUA

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2049079	LUC00006	Luxembourg	⤷ Try a Trial	PRODUCT NAME: CYCLOSPORINE (GOUTTES OCULAIRES SOUS FORME D'EMULSION); AUTHORISATION NUMBER AND DATE: EU/1/15/990 20150323
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Summary for CEQUA

Pharmacology for CEQUA

Patents protecting CEQUA

Make Better Decisions: Try a trial or see plans & pricing